Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells
Author:
Funder
Bergen County Academies
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference21 articles.
1. Triple-negative breast cancer: epidemiological considerations and recommendations;Boyle;Ann. Oncol.,2012
2. Chemoresistance in human ovarian cancer: the role of apoptotic regulators;Fraser;Reprod. Biol. Endocrinol.,2003
3. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects;Florea;Cancers,2011
4. alpha-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53, triple-negative human breast cancer cells via activating p73;Tiwary;Breast Cancer Res.,2011
5. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions;Eischen;Blood,1997
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer;Translational Oncology;2024-08
2. CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer;Biology;2024-06-28
3. Resistance to taxane chemotherapies in prostate cancer;Therapy Resistance in Prostate Cancer;2024
4. Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis;Scientific Reports;2023-04-21
5. Cancer stem cell markers interplay with chemoresistance in triple negative breast cancer: A therapeutic perspective;Bulletin du Cancer;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3